Syncope, a temporary loss of consciousness due to inadequate cerebral blood flow, presents a diagnostic challenge in clinical practice. It accounts for approximately 1% of hospital admissions, necessitating a comprehensive approach for effective diagnosis and management.
Initial evaluation should include a detailed history and physical examination, focusing on pre-syncopal symptoms, triggers, and recovery period. Orthostatic blood pressure measurements and electrocardiogram (ECG) are essential in identifying underlying cardiac conditions. Further, risk stratification tools like the San Francisco Syncope Rule and the Canadian Syncope Risk Score can guide decision-making.
When initial evaluation is inconclusive, further diagnostic modalities may be employed. Carotid sinus massage can reveal carotid sinus hypersensitivity, while tilt-table testing can diagnose neurocardiogenic syncope. Ambulatory ECG monitoring is useful in detecting intermittent arrhythmias. Advanced imaging techniques like echocardiography or cardiac MRI can identify structural heart disease.
Treatment should be tailored according to the underlying cause and patient's risk profile. Non-pharmacological interventions, such as lifestyle modifications and physical counterpressure manoeuvres, are often first-line. Pharmacological treatment options include beta-blockers, fludrocortisone, and midodrine. In refractory cases or high-risk patients, cardiac pacing or implantable cardioverter-defibrillators may be necessary.
Managing syncope in clinical practice requires a meticulous approach, beginning with a thorough history and physical examination, followed by appropriate diagnostic testing. Treatment strategies should be individualized, considering the underlying cause and patient's risk profile. By adopting a comprehensive approach, clinicians can effectively diagnose and manage this common, yet often perplexing, clinical entity.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation